Why Turning Point Brands Stock Fell 15.5% This Week

MrDecoder · 2026-04-04T18:48:27+00:00

Turning Point Brands saw a 15.5% drop in stock price due to FDA hesitance in approving new nicotine pouch licenses amid health concerns. Despite this, its revenue from pouches has significantly increased, suggesting potential long-term value.

MrDecoder

2026-04-04 18:48:27

Abstract generation in progress

Turning Point Brands (TPB 3.03%) fell 15.5% this week, according to data from S&P Global Market Intelligence. The company with brands in tobacco rolling papers, chewing tobacco, and the fast-growing nicotine pouch category was hit because of reports of slowing approvals for nicotine pouches from the Food and Drug Administration (FDA).

Here’s why the stock was falling this week and whether it belongs in your portfolio right now.

Expand

NYSE: TPB

Turning Point Brands

Today’s Change

(-3.03%) $-2.25

Current Price

$72.00

Key Data Points

Market Cap

$1.4B

Day’s Range

$71.10 - $74.65

52wk Range

$51.48 - $146.90

Volume

37K

Avg Vol

405K

Gross Margin

57.08%

Dividend Yield

0.42%

Hesitant FDA approvals

Cigarette usage is declining in the United States, but is being replaced by nicotine pouches. These tobacco-free pouches offer a cleaner feel than chewing tobacco, making them more accessible for everyday life and popular among a wider customer base.

Turning Point Brands’ stock had soared on the back of its fast-growing nicotine pouch brands, led by Fre cans. Revenue from the segment grew 266% year-over-year last quarter to $41.3 million, making up 34% of total company revenues. Guidance calls for net revenue of $180 million to $190 million for the category in 2026.

This week, reports have surfaced that the FDA is hesitant to grant new pouch licenses in the United States due to unknown health impacts and their use among younger kids. It could be a scare that was similar to the vaping epidemic around a decade ago.

Image source: Getty Images.

Time to buy?

After reporting disappointing earnings, Turning Point Brands’ stock is down 50% from its highs and is declining further. Shares have a market cap of $1.3 billion, which could be cheap, given the steady revenue from rolling papers, chewing tobacco, and nicotine pouches.

If you believe that this FDA reporting is only a small bump in the road, then Turning Point Brands could be a good stock to buy for your portfolio today.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes